Thalidomide

Real-world data on upfront subcutaneous bortezomib-containing regimens for newly diagnosed myeloma

Cassiopeia: analysis of daratumumab maintenance for myeloma

AGMT MM 02: outcomes and time to best response in myeloma

Treating elderly myeloma: frailty scoring and latest trial data

A new era of treatment for multiple myeloma

Should every myeloma patient receive first-line daratumumab?

Treating young patients with myeloma

Recommendations for the management of myeloma

Auto-allo tandem SCT for myeloma

Dara plus IRd treatment for newly-diagnosed myeloma

Quality of life in myeloma patients on carfilzomib-based therapy

Treatment approaches for ASCT-eligible myeloma patients in the frontline

New developments in maintenance therapy for multiple myeloma

The evolving role of IMiDs

The impact of CHIP expression on multiple myeloma treatment

PET/CT in multiple myeloma monitoring